Oligodendrogliomas

These #tumors start in #brain #glial cells called #oligodendrocytes. These tumors tend to grow slowly, but like astrocytomas, most of them can grow into (infiltrate) nearby brain tissue and cannot be removed completely bysurgery. Oligodendrogliomas sometimes spread along the CSF pathways but rarely spread outside the brain or spinal cord. As with astrocytomas, they can become more aggressive over time. Very aggressive forms of these tumors are known as anaplastic oligodendrogliomas. Only about 2% of broligodendrogliomas.

Chordomas

These rare tumors start in the bone at the base of the skull or at the lower end of the spine. Chordomas don’t start in the central nervous system, but they can injure the nearby brain or spinal cord by pressing on it.

These tumors are treated with surgery if possible, often followed by radiation therapy, but they tend to come back in the same area after treatment, causing more damage. They usually do not spread to other organs. For more information on chordomas, see our document Bone Cancer.

http://neurooncology.conferenceseries.com/

                                                        Astrocytomas

Astrocytomas are tumors that start in glial cells called astrocytes. About 2 out of 10 brain tumors are astrocytomas.

Most astrocytomas can spread widely throughout the brain and blend with the normal brain tissue, which can make them very hard to remove by surgery. Sometimes they spread along the cerebrospinal fluid (CSF) pathways. It is very rare for them to spread outside of the brain or spinal cord.

Astrocytomas are often classified as high grade, intermediate grade, or low grade, based largely on how the cells look under the microscope.

• High grade astrocytomas, known as glioblastomas (or glioblastoma multiforme), are the fastest growing. These tumors make up about two-thirds of astrocytomas and are the most common malignant brain tumors in adults.
• Intermediate-grade astrocytomas, or anaplastic astrocytomas, grow at a moderate rate.
• Low-grade (diffuse) astrocytomas tend to be slow growing, but they can become more aggressive and fast growing over time.
• Some low-grade types called non-infiltrating astrocytomas do not usually grow into nearby tissues and tend to have a good prognosis. These include pilocytic astrocytomas and dysembryoplastic neuroepithelial tumors (DNETs). They are more common in children than in adults.
  
  http://neurooncology.conferenceseries.com/

Gliomas

Gliomas are not a specific type of brain tumor. Glioma is a general term for a group of tumors that start in glial cells. A number of tumors can be considered gliomas, including glioblastoma (also known as glioblastoma multiforme), astrocytomas, oligodendrogliomas, and ependymomas. About 3 out of 10 of all brain tumors are gliomas. Most fast-growing brain tumors are gliomas.

                What are adult brain and spinal cord tumors?

Types of brain and spinal cord tumors in adults

Tumors that start in the brain (primary brain tumors) are not the same as tumors that start in other organs, such as the lung or breast, and then spread to the brain (metastatic or secondary brain tumors). In adults, metastatic tumors to the brain are actually more common than primary brain tumors. These tumors are not treated the same way. For example, breast or lung cancers that spread to the brain are treated differently from tumors that start in the brain.

This document is only about primary brain and spinal cord tumors, not those that have spread to the brain and spinal cord from elsewhere in the body.

Unlike cancers that start in other parts of the body, tumors that start in the brain or spinal cord rarely spread to distant organs. Even so, tumors of the brain or spinal cord are rarely considered benign (non-cancerous). They can still cause damage by growing and spreading into nearby areas, where they can destroy normal brain tissue. And unless they are completely removed or destroyed, most brain or spinal cord tumors will continue to grow and eventually be life-threatening.

                                                    Malignant brain Tumors


In Dubai Every year about 2000 people are affected with brain and spinal cord tumors including children. Every year about 1,400 malignant brain Tumors are diagnosed in Dubai out of which about 100 of these cases in Children and About 80 people are diagnosed with other Malignant Central nervous system tumors, including malignant and spinal tumors, about in five of these are children. Patients diagnosed with glioblastoma, the most aggressive form of glioma, their prognosis remains poor with the majority of patients dying from the disease within the two years of diagnosis.

http://neurooncology.conferenceseries.com/

                                                    Preventing of Brain Cancer

Everyone engrossed in the subsequent emerging of Brain Tumor healthcare proficiency mainly in preventing of Brain Cancer is pressurize to attend. Fasten with our social network pages to get regular industry updates.

http://neurooncology.conferenceseries.com/

Neuro-oncology is a very complex field, where multi-disciplinarily is the leading word and it represents the only way to effectively tackle important and still unmet medical needs, such as treatment of brain tumors and management of treatment-related side effects. Innovative treatments, advances in neuro-imaging, improvement in the knowledge of cancer biology, palliative care and preclinical models will be among the main topics of the congress.

The field of research is focused on the side effect of chemotherapy on the peripheral nervous system, a small aspect of neuro-oncology. However, as a neurologist I am well aware of the relevance of the problems more broadly related to the diagnosis and care of brain tumor patients, and of the need of an intensive collaboration with neurosurgeons, radiotherapist, oncologist as well as other healthcare providers in order to optimize our efforts and to maximize their results, is said by Bruno Giometto, Vice President Italian Society of Neurology.”

http://neurooncology.conferenceseries.com/

Exploring Emerging Markets in NeuroOncology

The multinational market for brain cancer was valued at $500 million in 2012 and is expect to reach $1.1 billion by 2017, at a CAGR of 12.5%. Considerations like increased scope of neurological & immunological studies, clinical trials; rise in awareness for health & government and institution funds for research have exceedingly furnished for the ascending claim for the neuro oncologists, neurologists market. North America is the market leader with a share of ~40% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. Yet the Asia-Pacific sector renders a momentous development possibility for the neurology & Oncologists emporium through the prognosis period of 2015 to 2019. 

http://neurooncology.conferenceseries.com/

                                              Speaker Opportunity at Neuro Oncology

Global Neurooncology Conference Series

Conference Series is the contributory of administering multinational Neurological meetings for seven years, and much adrenalized to expand Asia Pacific ,Europe, American continents. Previous meetings were held in major cities like Brisbane Australia, with success the meetings again scheduled in three continents. 2th Neurooncology Meeting to be held during April 24-25th, 2017 at Dubai, UAE. 11th International Conference on Neurology and therapeutics was scheduled in Madrid, Spain, Europe. 10th Conference on Neurology and Neurochemistry planned to be conducted at Amsterdam, Netherlands February 27-28 2017. 

http://neurooncology.conferenceseries.com/

                                                            Recognizing the Brain cancer

Conference Theme: New Challenges and Latest Developments in Understanding Neuro-oncology and treating Brain Tumour

http://neurooncology.conferenceseries.com/abstract-submission.php

Brain Cancer agora is segregate on the basis of cancer diagnosis and brain therapeutics. A brain cancer involves the growth of idiosyncratic cells in the tissues of the brain. cardinal  brain cancer involves malignant tumor, Brain stem tumors, germ cell fibroadenoma, pituitary adenomas, Tumor development, DIPG, Cellular biology of brain cancer, primary CNS lymphomas, Pathophysiology and  peril aspect of brain cancer and prognosis of brain tumors.   

                                                  Challenges in Neuro-Oncology

The field of research is focused on the side effect of chemotherapy on the peripheral nervous system, a small aspect of neuro-oncology. However, as a neurologist I am well aware of the relevance of the problems more broadly related to the diagnosis and care of brain tumor patients, and of the need of an intensive collaboration with neurosurgeons, radiotherapist, oncologist as well as other healthcare providers in order to optimize our efforts and to maximize their results, is said by Bruno Giometto, Vice President Italian Society of Neurologyhttp://neurooncology.conferenceseries.com/registration.php

                                                  Challenges in Neuro-Oncology

The field of research is focused on the side effect of chemotherapy on the peripheral nervous system, a small aspect of neuro-oncology. However, as a neurologist I am well aware of the relevance of the problems more broadly related to the diagnosis and care of brain tumor patients, and of the need of an intensive collaboration with neurosurgeons, radiotherapist, oncologist as well as other healthcare providers in order to optimize our efforts and to maximize their results, is said by Bruno Giometto, Vice President Italian Society of Neurologyhttp://neurooncology.conferenceseries.com/registration.php

                                   Neurobiology of brain cancer

Brain Cancer agora is segregate on the basis of cancer diagnosis and brain therapeutics. A brain cancer involves the growth of idiosyncratic cells in the tissues of the brain. cardinal  brain cancer involves malignant tumor, Brain stem tumors, germ cell fibroadenoma, pituitary adenomas, Tumor development, DIPG, Cellular biology of brain cancer, primary CNS lymphomas, Pathophysiology and  peril aspect of brain cancer and prognosis of brain tumors.

http://neurooncology.conferenceseries.com/

                                   Neurobiology of brain cancer

Brain Cancer agora is segregate on the basis of cancer diagnosis and brain therapeutics. A brain cancer involves the growth of idiosyncratic cells in the tissues of the brain. cardinal  brain cancer involves malignant tumor, Brain stem tumors, germ cell fibroadenoma, pituitary adenomas, Tumor development, DIPG, Cellular biology of brain cancer, primary CNS lymphomas, Pathophysiology and  peril aspect of brain cancer and prognosis of brain tumors.

http://neurooncology.conferenceseries.com/

                                                  Brain cancer Awareness 

 

http://neurooncology.conferenceseries.com/

Neuro-oncology is a very complex field, where multi-disciplinarily is the leading word and it represents the only way to effectively tackle important and still unmet medical needs, such as treatment of brain tumors and management of treatment-related side effects. Innovative treatments, advances in neuro-imaging, improvement in the knowledge of cancer biology, palliative care and preclinical models will be among the main topics of the congress.

The multinational  market for brain cancer was valued at $500 million in 2012 and is expect to reach $1.1 billion by 2017, at a CAGR of 12.5%. Considerations like increased scope of neurological & immunological studies, clinical trials; rise in awareness for health & government and institution funds for research have exceedingly furnished for the ascending claim

http://neurooncology.conferenceseries.com/for the neuro oncologists, neurologists market.

2nd International Conference on Neuro Oncology and Brain Tumour April 24-25, 2017 Dubai, UAE